The Patent Finder
US

Opioid Receptor Modulator Dosage Formulations

US 11,311,516 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Allergan, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Mar 14, 2033 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Sep 22, 2021 as application 17/481,874 · Granted Apr 26, 2022
Base term, 20 years from filing
Today
20 years from filing
2013 2033
Clock starts
Mar 14, 2013
Term ends
Mar 14, 2033
Granted
Apr 26, 2022
base term fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,188,632, US 11,007,179, US 11,090,291, US 11,160,792, US 11,229,627, US 9,675,587, to Mar 14, 2033. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 14, 2013, when application 13/829,984, the earliest non-provisional in its chain, was filed (this one was filed Sep 22, 2021); a parent in its chain could not be resolved (the next row)Mar 14, 2033High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,188,632, US 11,007,179, US 11,090,291, US 11,160,792, US 11,229,627, US 9,675,587)resolves to Mar 14, 2033, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 14, 2033Medium confidence

Partial family

US 9,675,587In force
Mar 2033
Mar 2033
US 10,188,632In force
Mar 2033
Mar 2033
Application 16/213,083No file history here
not computed
not computed
Application 16/459,947No file history here
not computed
not computed
Application 16/795,044No file history here
not computed
not computed
US 11,007,179In force
Mar 2033
Mar 2033
US 11,090,291In force
Mar 2033
Mar 2033
US 11,160,792In force
Mar 2033
Mar 2033
8 of 14 applications in this family shown, earliest filings first. Partial: 5 of the 14 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 27, 2021
Reel 57932, frame 492
Jans, Eugeen Maria Jozef; Heyns, Philip Erna H.; Ceulemans, Jens JozefJanssen Pharmaceutica N.V.Assignment of Assignor's Interest
Oct 27, 2021
Reel 57932, frame 529
Costello, TimFuriex Pharmaceuticals, Inc.Assignment of Assignor's Interest
Oct 27, 2021
Reel 57932, frame 577
Janssen Pharmaceutica N.V.Furiex Pharmaceuticals, Inc.Assignment of Assignor's Interest
Oct 27, 2021
Reel 57940, frame 907
Furiex Pharmaceuticals, Inc.Furiex Pharmaceuticals, LLCChange of Name
Oct 27, 2021
Reel 57932, frame 679
Furiex Holdings Unlimited CompanyForest Tosara LimitedAssignment of Assignor's Interest
Oct 27, 2021
Reel 57940, frame 912
Furiex Pharmaceuticals, LLCFuriex Holdings Unlimited CompanyAssignment of Assignor's Interest
Oct 27, 2021
Reel 57932, frame 834
Forest Tosara LimitedAllergan Holdings Unlimited CompanyAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited